Ophthalmology · Santurce, PR
NPI
1053501411
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
611 Calle Dr Pavia Fernandez, Pavia Medical Plaza Suite 209
Santurce, PR, 00909
Phone (787) 728-2318
Medicare paid, 2024
$19K
348 services
Medicare patients, 2024
73
Average age 77
Drug cost, 2024
$810K
6,137 prescriptions
Company payments, 2025
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nadya Y Villalba-Ramos was code 92012 (ophthalmological e&m), 131 times for 65 patients. In total Nadya Y Villalba-Ramos billed 348 services in 20 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 131 | 65 | $62.26 | $8,156 |
| 92133 Computerized Ophthalmic Imaging | Office | 50 | 45 | $24.82 | $1,241 |
| 92134 Computerized Ophthalmic Imaging | Office | 39 | 36 | $26.00 | $1,014 |
| 92083 Vision, Hearing, and Speech Services | Office | 34 | 33 | $43.86 | $1,491 |
| 92201 Ophthalmological E&M | Office | 22 | 22 | $17.45 | $384 |
| 92250 Angiography | Office | 20 | 20 | $28.17 | $563 |
| 92020 Ophthalmological E&M | Office | 16 | 16 | $14.90 | $238 |
By year: 2022 $20K for 261 services; 2023 $19K for 288 services; 2024 $19K for 348 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nadya Y Villalba-Ramos prescribed most often to Medicare patients was Lumigan (Bimatoprost), with 912 prescriptions and refills. In total Nadya Y Villalba-Ramos wrote 6,137 Medicare prescriptions that cost $810K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lumigan Bimatoprost | 912 | 1,026 | 176 | $245K |
| Latanoprost Generic | 594 | 746 | 121 | $7,332 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 560 | 988 | 161 | $19K |
| Prednisolone Acetate Generic | 441 | 528 | 150 | $16K |
| Brimonidine Tartrate Generic | 331 | 378 | 70 | $7,622 |
| Simbrinza Brinzolamide/Brimonidine Tart | 265 | 342 | 55 | $56K |
| Timolol Maleate Generic | 258 | 317 | 51 | $4,048 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 209 | 230 | 45 | $28K |
| Vyzulta Latanoprostene Bunod | 204 | 224 | 37 | $55K |
| Ketorolac Tromethamine Generic | 203 | 297 | 96 | $9,787 |
| Dorzolamide Hcl Generic | 188 | 267 | 51 | $5,508 |
| Combigan Brimonidine Tartrate/Timolol | 140 | 146 | 25 | $29K |
| Alphagan P Brimonidine Tartrate | 123 | 135 | 33 | $28K |
| Rhopressa Netarsudil Mesylate | 120 | 139 | 40 | $39K |
| Carteolol Hcl Generic | 119 | 139 | 28 | $2,195 |
Brand drugs: 3,340 claims; generic drugs: 2,797 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nadya Y Villalba-Ramos $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.